SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ingargiola Luisa – ‘4’ for 6/30/22 re: BioCorRx Inc.

On:  Thursday, 7/7/22, at 6:05pm ET   ·   For:  6/30/22   ·   As:  Director   ·   Accession #:  1477932-22-4882   ·   File #:  0-54208

Previous ‘4’:  ‘4’ on 7/5/22 for 6/30/22   ·   Next:  ‘4’ on 10/4/22 for 9/30/22   ·   Latest:  ‘4’ on 4/16/24 for 4/12/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/07/22  Ingargiola Luisa                  4          Director    1:5K   BioCorRx Inc.                     Discount Edgar/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      5K 
                Securities by an Insider -- form4.xml/3.6                        




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  2022- 6/30/05:00
Not Subject to Section 16?  No
Issuer:
Issuer CIK:  1443863
Issuer Name:  BioCorRx Inc.
Issuer Trading Symbol:  BICX
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1447277
Owner Name:  Ingargiola Luisa
Reporting Owner Address:
Owner Street 1:  2390 EAST ORANGEWOOD
Owner Street 2:  SUITE 500
Owner City:  ANAHEIM
Owner State:  CA
Owner ZIP Code:  92806
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock, par value $0.001
Transaction Date:
Value:  2022- 6/30/05:00
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  A
Equity Swap Involved?  No
Footnote ID:  F1
Transaction Amounts:
Transaction Shares:
Value:  2092
Transaction Price Per Share:
Value:  0.00
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  25,906
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.39.
Remarks:
Owner Signature:
Signature Name:  /s/ Luisa Ingargiola
Signature Date:  2022- 7/7/05:00


Top
Filing Submission 0001477932-22-004882   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 7:26:54.2pm ET